← Back to Search

Heart Failure Optimization at Home to Improve Outcomes (Hozho): A Pragmatic in Navajo Nation (Hozho Trial)

N/A

Waitlist Available

Led By Lauren Eberly, MD, MPH

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1, 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to reduce heart failure hospitalizations and mortality in Navajo Nation by getting heart failure patients on appropriate medications and providing support.

Eligible Conditions

Congestive Heart Failure
Heart Failure

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Dose change of Aldosterone receptor antagonists

Dose change of Angiotensin Receptor-Neprilysin Inhibitor

Dose change of Angiotensin receptor blockers

+8 more

Other study objectives

Patient and Provider Satisfaction

Provider Comfort with Guideline Directed Medical Therapy prescribing

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Telehealth ModelActive Control1 Intervention

Patient enrolled in the GDMT Telehealth HF improvement program in which hone BP cuff is provided and medication is initiated and titrated over the phone

Group II: ControlActive Control1 Intervention

Usual care, control group

Do I qualify?Apply below to find out